*	OR T2 T1
R1	Has_temporal Arg1:T2 Arg2:T3	
R2	Has_qualifier Arg1:T7 Arg2:T8	
R3	Has_value Arg1:T9 Arg2:T10	
R4	Has_value Arg1:T11 Arg2:T12	
*	OR T9 T11
R5	Subsumes Arg1:T7 Arg2:T9	
*	OR T16 T15
R6	Has_qualifier Arg1:T14 Arg2:T16	
*	OR T19 T20
R7	Has_value Arg1:T18 Arg2:T19	
R8	Subsumes Arg1:T14 Arg2:T18	
*	OR T7 T14
R9	Subsumes Arg1:T22 Arg2:T23	
R10	Has_context Arg1:T22 Arg2:T25	
R11	Has_qualifier Arg1:T27 Arg2:T28	
R12	Subsumes Arg1:T27 Arg2:T29	
R13	Has_value Arg1:T27 Arg2:T30	
R14	Subsumes Arg1:T31 Arg2:T32	
R15	Has_value Arg1:T31 Arg2:T33	
*	OR T27 T31
R16	Has_qualifier Arg1:T34 Arg2:T35	
*	OR T39 T40
R17	Has_value Arg1:T38 Arg2:T39	
R18	Has_temporal Arg1:T42 Arg2:T43	
R19	Subsumes Arg1:T37 Arg2:T38	
*	OR T34 T36 T37 T42
R20	Has_temporal Arg1:T44 Arg2:T45	
R21	Has_qualifier Arg1:T48 Arg2:T50	
R22	Has_qualifier Arg1:T48 Arg2:T52	
*	OR T48 T49 T47
R23	Has_negation Arg1:T48 Arg2:T46	
R24	Has_temporal Arg1:T53 Arg2:T54	
R25	Has_temporal Arg1:T55 Arg2:T56	
R26	Has_index Arg1:T58 Arg2:T59	
R27	Has_temporal Arg1:T57 Arg2:T58	
R28	AND Arg1:T60 Arg2:T61	
R29	Has_index Arg1:T62 Arg2:T63	
R30	Has_temporal Arg1:T60 Arg2:T62	
T1	Condition 30 45	substance abuse
T2	Condition 19 26;40 45	alcohol abuse
T3	Temporal 53 72	preceding 12 months
T5	Pregnancy_considerations 75 114	Women who are pregnant or breastfeeding
T6	Pregnancy_considerations 117 210	Women of childbearing potential (WOCP) who are not using at least one method of contraception
T7	Condition 234 250	renal impairment
T8	Qualifier 227 233	severe
T9	Measurement 252 256	CLcr
T10	Value 257 268	= 29 mL/min
T11	Measurement 273 277	eGFR
T12	Value 278 297	= 29 mL/min/1.73 m2
T14	Condition 322 340	hepatic impairment
T15	Qualifier 315 321	severe
T16	Qualifier 303 311	moderate
T18	Measurement 342 360	Child-Pugh classes
T19	Value 361 362	B
T20	Value 366 367	C
T22	Condition 385 411	bladder outlet obstruction
T23	Condition 413 416	BOO
T24	Drug 532 542	mirabegron
T25	Observation 484 509	risk of urinary retention
T26	Non-query-able 545 606	Patients treated with drugs metabolized by the CYP2D6 pathway
T27	Measurement 630 653	systolic blood pressure
T28	Qualifier 623 629	supine
T29	Measurement 655 658	SBP
T30	Value 660 671	= 180 mm Hg
T31	Measurement 676 700	diastolic blood pressure
T32	Measurement 702 705	DBP
T33	Value 707 718	= 110 mm Hg
T34	Condition 758 776	cardiac arrhythmia
T35	Qualifier 745 757	uncontrolled
T36	Condition 778 793	unstable angina
T37	Condition 795 819	congestive heart failure
T38	Measurement 821 831	NYHA Class
T39	Value 832 833	3
T40	Value 837 838	4
T42	Condition 855 876	myocardial infarction
T43	Temporal 884 901	preceding 2 years
T44	Condition 915 921	cancer
T45	Temporal 929 946	preceding 2 years
T46	Negation 947 952	other
T47	Condition 1038 1061	cervical cancer in situ
T48	Condition 1013 1033	basal cell carcinoma
T49	Condition 1024 1033;996 1009	carcinoma squamous cell
T50	Qualifier 980 994	non-metastatic
T52	Qualifier 958 978	successfully treated
T53	Procedure 1068 1094	major urological procedure
T54	Temporal 1102 1119	preceding 90 days
T55	Procedure 1126 1150	major surgical procedure
T56	Temporal 1158 1175	preceding 30 days
T57	Drug 1202 1212	mirabegron
T58	Temporal 1213 1255	within 60 days prior to the baseline visit
T59	Reference_point 1241 1255	baseline visit
T60	Drug 1465 1486	antimuscarinic agents
T61	Condition 1491 1503	OAB symptoms
T62	Temporal 1391 1438	within the 60 days preceding the baseline visit
T63	Reference_point 1424 1438	baseline visit
T64	Post-eligibility 1510 1584	willingness to not use antimuscarinic agents for the duration of the study
T65	Competing_trial 1587 1738	Currently receiving any other investigational drug or having received an investigational drug within the 60 days preceding the baseline visit (Visit 2)
T66	Non-query-able 1741 1946	Any condition or laboratory test result, which, in the opinion of the Investigator or the Study Urologist, might result in an increased risk to the patient, or would affect their participation in the study
T67	Non-query-able 1949 2086	Any patient who, in the opinion of the Investigator, is not a good candidate for the study or will not be able to follow study procedures
